Glioblastoma is a devastating primary brain tumor consisting of multiple cell populations. We identified TFPI2 as the crucial effector of the symbiotic interaction between glioblastoma stem cells and microglia. Blockade of this symbiosis inhibited tumor growth and synergized with an immune checkpoint inhibitor in mouse models of glioblastoma.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pang, L., Khan, F., Heimberger, A. B. & Chen, P. Mechanism and therapeutic potential of tumor immune symbiosis in glioblastoma. Trends Cancer 8, 839–854 (2022). A review article that presents the key role of tumor–immune symbiosis in promoting tumor growth and inducing immunotherapy resistance in GBM.
Prager, B. C., Bhargava, S., Mahadev, V., Hubert, C. G. & Rich, J. N. Glioblastoma stem cells: driving resilience through chaos. Trends Cancer 6, 223–235 (2020). A review article that describes the key features of GSCs in GBM.
Chen, P., Hsu, W. H., Han, J., Xia, Y. & DePinho, R. A. Cancer stemness meets immunity: from mechanism to therapy. Cell Rep. 34, 108597 (2021). A review article that presents the interactions between cancer stem cells and the tumor microenvironment across cancer types, including GBM.
Xuan, W., Lesniak, M. S., James, C. D., Heimberger, A. B. & Chen, P. Context-dependent glioblastoma–macrophage/microglia symbiosis and associated mechanisms. Trends Immunol. 42, 280–292 (2021). A review article that describes TAMs in GBM.
Uhlen, M. et al. The human secretome. Sci. Signal. 12 (2019). This paper reports proteins predicted to be secreted in human cells.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Pang, L. et al. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma. Nat. Immunol. https://doi.org/10.1038/s41590-023-01605-y (2023).
Rights and permissions
About this article
Cite this article
TFPI2 is key for cancer stem cell–microglia symbiosis in glioblastoma. Nat Immunol 24, 1612–1613 (2023). https://doi.org/10.1038/s41590-023-01610-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01610-1
